

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $331.03
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Sep 29, 26 |
| JP Morgan |
| maintain |
| Overweight |
| Overweight |
| Sep 3, 26 | Lake Street | upgrade | Hold | Buy |
| Jun 5, 26 | Lake Street | maintain | Hold | Hold |
| Mar 27, 26 | JP Morgan | upgrade | Neutral | Overweight |
| Mar 27, 26 | Goldman Sachs | maintain | Buy | Buy |
| Mar 27, 26 | Lake Street | maintain | Hold | Hold |
| Dec 5, 25 | Lake Street | downgrade | Buy | Hold |
| Dec 1, 25 | JP Morgan | downgrade | Overweight | Neutral |
| Nov 10, 25 | GLJ Research | upgrade | Hold | Buy |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 31.32 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 9.18 | Oscillator | Buy |
| Williams %R (14) | -87.38 | Oscillator | Buy |
| MACD (12, 26, 9) | -20.49 (Hist -2.38) | Oscillator | Strong Sell |
| Average Directional Index (14) | 30.15 (+DI 10.7 / -DI 29.5) | Trend | Strong Sell |
| EMA 20 | 368.13 | MA | Strong Sell |
| SMA 20 | 372.24 | MA | Strong Sell |
| EMA 50 | 416.96 | MA | Strong Sell |
| SMA 50 | 409.63 | MA | Strong Sell |
| SMA 200 | 520.15 | MA | Strong Sell |
TTM vs. 5-year historical average (annual ratios)
| Metric | AGX | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 25.7x | 21.3x · sector 18.4x | Elevated |
| Forward P/E (FY27E) | 25.0x | EPS est. 13.22 | In line |
| Price / Book | 9.2x | 4.3x | Elevated |
| Price / Sales | 3.9x | 2.1x | Elevated |
| EV / EBITDA | 19.6x | 12.3x | Elevated |
| Return on equity | 38.5% | — | Top tier |
| Gross margin | 20.9% | 17.9% | Above hist. |
| Debt / Equity | 0.00 | 0.01 | Conservative |
| Piotroski / Altman Z | 5/9 | Z 5.33 | Safe zone |
Discounted cash flow model
Stock news · updated daily
AGX's ValCor acquisition could double Teledata revenues as data-center demand grows, while $1.03 billion in cash supports expansion and future opportunities.
Investors with an interest in Building Products - Miscellaneous stocks have likely encountered both Jacobs Solutions (J) and Argan (AGX). But which of these two companies is the best option for those looking for undervalued stocks?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
In Q3 2026, 149 dividend-paying stocks announced increases, with an average hike of 7.93% and a median yield of 2.79%. Financials led sector increases, while Health Care posted the highest average increase; larger increases correlated with lower yields. Three companies cut dividends, all flagged as low quality or with weak safety scores prior to the reduction. Six companies declared special dividends.
Argan, Inc. AGX has delivered a strong run in 2026, with shares gaining 25.3% year to date (“YTD”). The stock has outperformed the Zacks Building Products - Miscellaneous industry's 10.7% fall, the Zacks Construction sector's 1.1% decline and the S&P 500 Index's 14.6% gain.
Can AGX turn its $1 billion cash and investments into sustained growth? Its ValCor acquisition, shareholder returns and expansion plans highlight the financial flexibility.
Investors need to pay close attention to AGX stock based on the movements in the options market lately.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Sep 2, 2026 | 2.64 | 3.76 | Beat 42.4% | $384.0M |
| Jun 4, 2026 | 2.31 | 3.24 | Beat 40.3% | $291.0M |
| Mar 26, 2026 | 1.99 | 3.47 | Beat 74.4% | $262.1M |
| Dec 4, 2025 | 2.05 | 2.17 | Beat 5.9% | $251.2M |
| Sep 4, 2025 | 1.99 | 2.50 | Beat 25.6% | $237.7M |
| Jun 4, 2025 | 1.09 | 1.60 | Beat 46.8% | $193.7M |
FY2026 · 10-K disclosure
FY2026 · 10-K disclosure
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Sep 22, 26 | Getsinger Peter W | director | M-Exempt | 895 @ $40.15 | $35.93K |
| Sep 22, 26 |
| Getsinger Peter W |
| director |
| M-Exempt |
| 1,000 @ $40.15 |
| $40.15K |
| Sep 9, 26 | Collins Charles Edwin Iv | officer: CHIEF EXECUTIVE OFFICER, GEMMA | A-Award | 3,506 | — |
| Jul 31, 26 | Jeffrey John Ronald Jr. | director | S-Sale | 5,716 @ $579.64 | $3.31M |
| Jun 30, 26 | Jeffrey John Ronald Jr. | director | M-Exempt | 944 @ $43.70 | $41.25K |
| Jun 30, 26 | Jeffrey John Ronald Jr. | director | M-Exempt | 4,772 @ $35.72 | $170.5K |
| Jun 30, 26 | Jeffrey John Ronald Jr. | director | M-Exempt | 5,000 @ $35.72 | $178.6K |
| Jun 30, 26 | Jeffrey John Ronald Jr. | director | M-Exempt | 1,000 @ $43.70 | $43.70K |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 4 | Sep 23, 2026 | 2026-09-23 16:15:06 | View |
| 4 | Sep 11, 2026 | 2026-09-11 17:18:32 | View |
| 8-K | Sep 9, 2026 | 2026-09-09 16:15:10 | View |
| 10-Q | Sep 2, 2026 | 2026-09-02 16:20:48 | View |
| 8-K | Sep 2, 2026 | 2026-09-02 16:10:25 | View |
| 4 | Aug 4, 2026 | 2026-08-04 16:30:21 | View |
| 8-K | Aug 4, 2026 | 2026-08-04 16:20:20 | View |
| SC 13G | Jul 31, 2026 | 2026-07-31 11:24:38 | View |
| 4 | Jul 2, 2026 | 2026-07-02 16:30:07 | View |
| 4 | Jun 23, 2026 | 2026-06-23 17:00:14 | View |
Proxy statement (DEF 14A) disclosures